Legend Biotech (LEGN) News Today → A once-in-a-century investment opportunity (From Stansberry Research) (Ad) Free LEGN Stock Alerts $45.16 -1.21 (-2.61%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:02 AM | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Stock Holdings Increased by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,984,826 shares of the company's stock after purchasing aMay 16 at 6:58 AM | americanbankingnews.comLegend Biotech Co. (NASDAQ:LEGN) to Post Q2 2024 Earnings of ($0.14) Per Share, HC Wainwright ForecastsMay 16 at 6:58 AM | americanbankingnews.comWilliam Blair Brokers Boost Earnings Estimates for Legend Biotech Co. (NASDAQ:LEGN)May 16 at 4:58 AM | americanbankingnews.comLegend Biotech (NASDAQ:LEGN) PT Raised to $86.00May 15 at 5:39 PM | marketbeat.comFirst Turn Management LLC Purchases New Shares in Legend Biotech Co. (NASDAQ:LEGN)First Turn Management LLC acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 476,079 shares of the company's stock, valued at approximatMay 15 at 3:42 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)May 15 at 10:41 AM | msn.comLegend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call TranscriptMay 14, 2024 | markets.businessinsider.comBuy Rating for Legend Biotech Anchored by Carvykti’s Growth and Market Penetration PotentialMay 14, 2024 | marketbeat.comNicholas Investment Partners LP Trims Holdings in Legend Biotech Co. (NASDAQ:LEGN)Nicholas Investment Partners LP reduced its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 26,650 shares of the company's stock after selling 566,360 shares during the period.May 14, 2024 | markets.businessinsider.comLegend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)May 14, 2024 | marketbeat.comRoyal Bank of Canada Boosts Legend Biotech (NASDAQ:LEGN) Price Target to $86.00Royal Bank of Canada lifted their price target on shares of Legend Biotech from $85.00 to $86.00 and gave the stock an "outperform" rating in a report on Tuesday.May 14, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPSLegend Biotech (NASDAQ:LEGN - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.13. The business had revenue of $93.90 million during the quarter, compared to analyst estimates of $143.24 million. Legend Biotech had a negative net margin of 181.75% and a negative return on equity of 37.19%. The company's revenue for the quarter was up 158.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.40) EPS.May 14, 2024 | seekingalpha.comLegend Biotech's Carvykti Faces Stiff Challenges Despite AdvancesMay 14, 2024 | finance.yahoo.comLegend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...May 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Legend Biotech on CARVYKTI Growth and Positive Clinical DevelopmentsMay 14, 2024 | finance.yahoo.comQ1 2024 Legend Biotech Corp Earnings CallMay 13, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24May 13, 2024 | marketwatch.comLegend Biotech 1Q Loss Narrows with Higher Carvykti SalesMay 13, 2024 | seekingalpha.comLegend Biotech Corporation 2024 Q1 - Results - Earnings Call PresentationMay 13, 2024 | msn.comLegend Biotech Vaults on QuarterliesMay 13, 2024 | businesswire.comLegend Biotech Reports First Quarter 2024 Results and Recent HighlightsMay 12, 2024 | marketbeat.comJump Financial LLC Buys 74,272 Shares of Legend Biotech Co. (NASDAQ:LEGN)Jump Financial LLC lifted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 157.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,481 shares of the company's stock after pMay 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Increases Position in Legend Biotech Co. (NASDAQ:LEGN)TimesSquare Capital Management LLC lifted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,065,889 shares of the company's stock after buying anMay 9, 2024 | marketbeat.comLegend Biotech's (LEGN) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $87.00 price target on shares of Legend Biotech in a report on Thursday.April 30, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $43.92Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low at $43.92April 23, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $87.00 price objective on shares of Legend Biotech in a report on Tuesday.April 23, 2024 | marketbeat.comSumitomo Mitsui Trust Holdings Inc. Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,130 shares of the company's stock afterApril 23, 2024 | markets.businessinsider.comHold Rating on Legend Biotech Amidst Approval of Carvykti and Commercial Manufacturing ChallengesApril 22, 2024 | businesswire.comCARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple MyelomaApril 22, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $45.52Legend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $45.52April 20, 2024 | msn.comFDA requires labeling changes to CAR-T cell therapies to reflect cancer riskApril 20, 2024 | marketbeat.comMackenzie Financial Corp Has $9.19 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Mackenzie Financial Corp grew its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,767 shares of the company's stock after buyingApril 19, 2024 | marketbeat.comFederated Hermes Inc. Decreases Position in Legend Biotech Co. (NASDAQ:LEGN)Federated Hermes Inc. trimmed its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,725,972 shares of the company's stock after selling 38,524 shares during the quarteApril 18, 2024 | marketbeat.comQ3 2024 EPS Estimates for Legend Biotech Co. Lifted by HC Wainwright (NASDAQ:LEGN)Legend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings estimates for shares of Legend Biotech in a research note issued to investors on Tuesday, April 16th. HC Wainwright analyst M. Kapoor now forecasts that the company will earnApril 17, 2024 | seekingalpha.comScotiabank upgrades Legend Biotech to sector outperformApril 17, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) to Post Q1 2024 Earnings of ($0.01) Per Share, HC Wainwright ForecastsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Research analysts at HC Wainwright cut their Q1 2024 earnings per share (EPS) estimates for Legend Biotech in a report released on Tuesday, April 16th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings of ($0.01) per sApril 17, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Raised to "Sector Outperform" at ScotiabankScotiabank raised Legend Biotech from a "sector perform" rating to a "sector outperform" rating and set a $65.00 target price for the company in a research report on Wednesday.April 17, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12April 17, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Purchases New Stake in Legend Biotech Co. (NASDAQ:LEGN)Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 60,492 shares of the company's stock,April 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Legend Biotech Amidst Anticipated Growth and Expanded Carvykti UseApril 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Legend Biotech Amidst Growth Prospects and CARVYKTI’s Market ExpansionApril 16, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Legend Biotech (NASDAQ:LEGN)HC Wainwright restated a "buy" rating and set a $87.00 price target on shares of Legend Biotech in a report on Tuesday.April 16, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Sets New 1-Year Low at $49.13Legend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $49.13April 14, 2024 | nasdaq.comLEGN Quantitative Stock AnalysisApril 14, 2024 | nasdaq.comLegend Biotech is Now Oversold (LEGN)April 11, 2024 | businesswire.comLegend Biotech to Host Investor Conference Call on First Quarter 2024 ResultsApril 10, 2024 | marketbeat.comQ2 2024 EPS Estimates for Legend Biotech Co. (NASDAQ:LEGN) Cut by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Research analysts at HC Wainwright reduced their Q2 2024 EPS estimates for shares of Legend Biotech in a research note issued to investors on Monday, April 8th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings perApril 9, 2024 | marketbeat.comQ1 2024 Earnings Forecast for Legend Biotech Co. Issued By HC Wainwright (NASDAQ:LEGN)Legend Biotech Co. (NASDAQ:LEGN - Free Report) - Stock analysts at HC Wainwright decreased their Q1 2024 earnings per share (EPS) estimates for Legend Biotech in a research note issued on Monday, April 8th. HC Wainwright analyst M. Kapoor now expects that the company will earn $0.01 per share forApril 9, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen analysts that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company.April 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Legend Biotech (LEGN) and Intellia Therapeutics (NTLA) Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address A once-in-a-century investment opportunity (Ad)It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead. To get its name and ticker symbol for free - just click here. LEGN Media Mentions By Week LEGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.550.50▲Average Medical News Sentiment LEGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼284▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VKTX News ELAN News CERE News ASND News JAZZ News ROIV News ITCI News BPMC News CYTK News CTLT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
